To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 November 2023 to Question 3472 on Cystic Fibrosis: Drugs, when she expects the National Institute for Health and Care Excellence to publish their final guidance on the 
The National Institute for Health and Care Excellence (NICE) published draft guidance on 3 November 2023 which does not recommend Orkambi (lumacaftor-ivacaftor), Symkevi (ivacaftor-tezacaftor) and Kaftrio (ivacaftor–tezacaftor–elexacaftor) for the treatme...
Ivacaftor/tezacaftor/elexacaftor